4.2 Article

Indoleamine 2,3-Dioxygenase Activity and Expression in Patients With Chronic Lymphocytic Leukemia

Journal

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Volume 12, Issue 5, Pages 363-365

Publisher

CIG MEDIA GROUP, LP
DOI: 10.1016/j.clml.2012.06.001

Keywords

B cell; Immunity; Kynurenine; Lymphoproliferative disease; Tryptophan

Funding

  1. Medical Research Fund of Pirkanmaa Hospital District

Ask authors/readers for more resources

Indoleamine 2,3-dioxygenase (IDO) activity and expression is increased in many hematological malignancies, but has not been previously studied in chronic lymphocytic leukemia (CLL). We determined IDO activity and expression in 49 patients with CLL. We found that IDO activity is increased in CLL. This may have some influence on CLL progression. Background: Indoleamine 2,3-dioxygenase (IDO) is an enzyme involved in the catabolism of tryptophan, suppressing T-cell activity. IDO activity and expression are increased in many malignant diseases, including hematological malignancies. IDO expression can mediate immunotolerance to tumors. IDO activity and expression have not previously been studied in chronic lymphocytic leukemia (CLL). Methods: We measured IDO activity by calculating the kynurenine-tryptophan (kyn-trp) ratio. IDO and IDO2 gene expression was determined by using real-time polymerase chain reaction (PCR). Results: In patients with CLL, the serum kyn-trp ratio reflecting increased IDO activity was significantly higher compared with controls, but in peripheral blood mononuclear cells (PBMCs) mainly representing malignant B cells the expression of genes encoding IDO and IDO2 enzymes was reduced. Conclusions: Increased IDO activity in patients with CLL may affect disease progression, although it originates from cells other than malignant B cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Public, Environmental & Occupational Health

Comparison of two different frailty scales in the longitudinal Swedish Adoption/Twin Study of Aging (SATSA)

Alexandra M. Wennberg, Weiyao Yin, Fang Fang, Nancy L. Pedersen, Sara Hagg, Juulia Jylhava, Karin Modig

Summary: This study evaluated the utility of a code-based frailty score in registry data and found that it may not capture the full spectrum of frailty among community-dwelling individuals, particularly at younger ages.

SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2023)

Article Geriatrics & Gerontology

Genetic and Environmental Influences on Longitudinal Frailty Trajectories From Adulthood into Old Age

Jonathan K. L. Mak, Ralf Kuja-Halkola, Ge Bai, Linda B. Hassing, Nancy L. Pedersen, Sara Hagg, Juulia Jylhava, Chandra A. Reynolds

Summary: Using data from Swedish twin cohort studies, this research investigates the longitudinal trajectories of frailty in late life and the contributions of genes and environment. The study finds that the heterogeneity of frailty in late life is mainly attributable to environmental influences, highlighting the importance of targeting environmental risk factors to mitigate frailty in older adults.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2023)

Article Peripheral Vascular Disease

Urine sodium excretion is related to extracellular water volume but not to blood pressure in 510 normotensive and never-treated hypertensive subjects

Jyrki Taurio, Jenni Koskela, Marjatta Sinisalo, Antti Tikkakoski, Onni Niemela, Mari Hamalainen, Eeva Moilanen, Manoj Kumar Choudhary, Jukka Mustonen, Pasi Nevalainen, Ilkka Porsti

Summary: In this study, we examined the association of 24-hour urine sodium excretion with haemodynamics and volume status in 510 normotensive and never-treated hypertensive subjects. The results showed that high sodium excretion was associated with increased extracellular fluid volume, while low sodium intake was associated with increased risk of cardiovascular events. The volume of extracellular fluid was mainly determined by body size, but was also moderately influenced by sodium intake. No differences were found in urinary sodium excretion and extracellular water volume between normotensive and hypertensive participants.

BLOOD PRESSURE (2023)

Article Geriatrics & Gerontology

Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study

Jonathan K. L. Mak, Maria Eriksdotter, Martin Annetorp, Ralf Kuja-Halkola, Laura Kananen, Anne-Marie Bostrom, Miia Kivipelto, Carina Metzner, Viktoria Back Jerlardtz, Malin Engstrom, Peter Johnson, Lars Goran Lundberg, Elisabet Akesson, Carina Suhl Oberg, Maria Olsson, Tommy Cederholm, Sara Hagg, Dorota Religa, Juulia Jylhava

Summary: This retrospective cohort study used electronic health records to investigate the association between frailty and outcomes in older COVID-19 patients. The results showed that a medical record-based electronic frailty index (eFI) was effective for risk stratification in hospitalized COVID-19 patients. Frailty was significantly associated with higher mortality, readmission, and longer hospital stays, and the eFI had the best predictive accuracy among all measures.

GERONTOLOGY (2023)

Article Geriatrics & Gerontology

Body Composition in Late Midlife as a Predictor of Accelerated Age-associated Deficit-accumulation From Late Midlife into Old Age: A Longitudinal Birth Cohort Study

Markus J. Haapanen, Tuija M. Mikkola, Lauri Kortelainen, Juulia Jylhava, Niko S. Wasenius, Eero Kajantie, Johan G. Eriksson, Mikaela B. von Bonsdorff

Summary: Body mass index (BMI) may not accurately predict frailty, as lean mass and fat mass may have different associations with frailty. Abdominal obesity (waist-to-hip ratio) in late midlife may be related to higher levels of frailty in men, while higher adiposity (percent body fat) in late midlife may be associated with higher levels of frailty in women.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2023)

Article Cell Biology

Unraveling the metabolic underpinnings of frailty using multicohort observational and Mendelian randomization analyses

Jonathan K. L. Mak, Laura Kananen, Chenxi Qin, Ralf Kuja-Halkola, Bowen Tang, Jake Lin, Yunzhang Wang, Tuija Jaaskelainen, Seppo Koskinen, Yi Lu, Patrik K. E. Magnusson, Sara Hagg, Juulia Jylhava

Summary: In this study, the researchers identified 59 metabolic biomarkers associated with frailty, and 34 of these associations were independently validated in other studies. They also found that glycoprotein acetyls, an inflammatory marker, was significantly associated with frailty, suggesting the important role of chronic inflammation in frailty development.

AGING CELL (2023)

Article Oncology

Clinical biomarker-based biological aging and risk of cancer in the UK Biobank

Jonathan K. L. Mak, Christopher E. McMurran, Ralf Kuja-Halkola, Per Hall, Kamila Czene, Juulia Jylhaevae, Sara Haegg

Summary: By studying 308,156 UK Biobank participants, researchers found a link between biological age and cancer incidence. Using 18 age-related clinical biomarkers, three biological age measures were calculated and found to be associated with the incidence of any cancer, breast cancer, prostate cancer, lung cancer, colorectal cancer, and melanoma.

BRITISH JOURNAL OF CANCER (2023)

Article Multidisciplinary Sciences

Health progression for Covid-19 survivors hospitalized in geriatric clinics in Sweden

Laura Kananen, Xu Hong, Martin Annetorp, Jonathan K. L. Mak, Juulia Jylhava, Maria Eriksdotter, Sara Hagg, Dorota Religa

Summary: This study aimed to analyze whether the health progression of geriatric Covid-19 survivors three months after the acute infection was worse than that of other geriatric patients. The results showed that the health of Covid-19 survivors did not significantly deteriorate compared to age, sex, and baseline health-matched non-Covid-19 patients after three months.

PLOS ONE (2023)

Article Geriatrics & Gerontology

Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging

Bowen Tang, Xia Li, Yunzhang Wang, Arvid Sjolander, Kristina Johnell, Madhav Thambisetty, Luigi Ferrucci, Chandra A. Reynolds, Deborah Finkel, Juulia Jylhava, Nancy L. Pedersen, Sara Hagg

Summary: This study examined the effects of antihypertensive, lipid-lowering, and antidiabetic drugs on biological aging. The results showed that the use of calcium channel blockers was associated with a decrease in DNA-methylation age and functional biological age. However, the effects of other drug subcategories were inconsistent.

GEROSCIENCE (2023)

Article Geriatrics & Gerontology

Can frailty scores predict the incidence of cancer? Results from two large population-based studies

Jonathan K. L. Mak, Ralf Kuja-Halkola, Yunzhang Wang, Sara Haegg, Juulia Jylhaevae

Summary: The study found that frailty index (FI) and frailty phenotype (FP) scores are associated with the incidence of any cancer and certain common cancers. However, the predictive utility of frailty scores for most cancers is limited.

GEROSCIENCE (2023)

Article Medicine, General & Internal

Genetically and environmentally predicted obesity in relation to cardiovascular disease: a nationwide cohort study

Elsa Ojalehto, Yiqiang Zhan, Juulia Jylhava, Chandra A. Reynolds, Anna K. Dahl Aslan, Ida K. Karlsson

Summary: The study found that the association between obesity and cardiovascular disease (CVD) differs based on genetically predicted BMI. People with genetically predicted lower BMI had a stronger association between midlife obesity and CVD compared to those with genetically predicted high BMI. However, there are additional genetic factors that were not captured by the genetic prediction models.

ECLINICALMEDICINE (2023)

Review Cell Biology

Recent developments in frailty identification, management, risk factors and prevention: A narrative review of leading journals in geriatrics and gerontology

Elsa Dent, Peter Hanlon, Marc Sim, Juulia Jylhava, Zuyun Liu, Davide L. Vetrano, Erwin Stolz, Mario Ulises Perez-Zepeda, Daniel R. Crabtree, Caroline Nicholson, Jenny Job, Rachel C. Ambagtsheer, Paul R. Ward, Sandra M. Shi, Quan Huynh, Emiel O. Hoogendijk

Summary: This narrative review provides critical insights into recent developments and emerging practices in frailty research. It highlights the importance of new biomarkers, artificial intelligence, and studying medication response in older adults with frailty. The review also emphasizes the need for cost-effective, community-based interventions and better support for older adults with frailty.

AGEING RESEARCH REVIEWS (2023)

Article Medicine, General & Internal

Risk of venous thromboembolism in COVID-19 infection

Meeri Honkanen, Simo Sirkeoja, Hanna Viskari, Ville Kailankangas, Marjatta Sinisalo, Jaana Syrjänen

Summary: The incidence of venous thromboembolism (VTE) in non-hospitalized COVID-19 patients has not been extensively studied. In a study of 13,019 individuals with positive SARS-CoV-2 tests, 447 cases (0.2%) of VTE were identified, with 293 (66%) being pulmonary embolisms. The analysis did not find a significant increase in VTE risk associated with a positive SARS-CoV-2 test.

INTERNAL MEDICINE JOURNAL (2023)

Article Genetics & Heredity

Rare functional variants in the CRP and G6PC genes modify the relationship between obesity and serum C-reactive protein in white British population

Xia Li, Alexander Ploner, Yunzhang Wang, Jonathan K. L. Mak, Yi Lu, Patrik K. E. Magnusson, Juulia Jylhava, Sara Hagg

Summary: This study found that PA mutation burdens in the CRP and G6PC genes were strongly associated with decreased serum CRP concentrations in participants from the UK Biobank. Additionally, the effects of obesity and central obesity on CRP concentration were smaller among PA mutation carriers. These findings suggest that considering rare genetic factors may improve the delivery of precision medicine in clinical settings.

MOLECULAR GENETICS & GENOMIC MEDICINE (2023)

Article Public, Environmental & Occupational Health

Anticoagulant treatment and COVID-19 mortality among older adults living in nursing homes in Sweden

Laura Kananen, Christian Molnar, Fredrik Ansker, Daria Julianna Kozlowska, Sara Hagg, Juulia Jylhava, Dorota Religa, Pauline Raaschou

Summary: The use of anticoagulants in nursing home residents diagnosed with COVID-19 in the Stockholm Region was associated with reduced 28-day mortality rates, especially in the 70-89 and 90-99 age groups and in women. The findings provide new insights for best practices in treating individuals with COVID-19 in nursing home settings.

HEALTH SCIENCE REPORTS (2023)

No Data Available